Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience

Aim: We assessed the role of adjuvant interferon on relapse-free survival (RFS), distant metastasis-free survival (DMFS) and overall survival (OS) in node-positive melanoma patients. Methods: We retrospectively reviewed 385 node-positive patients without distant metastatic disease treated from 1998...

Full description

Bibliographic Details

Published in:	Melanoma Management
Main Authors:	Daniel E Oliver, Vernon K Sondak, Tobin Strom, Jonathan S Zager, Arash O Naghavi, Amod Sarnaik, Jane L Messina, Jimmy J Caudell, Andy M Trotti, Javier F Torres-Roca, Nikhil I Khushalani, Louis B Harrison
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-03-01
Subjects:	cutaneous immunotherapy interferon melanoma survival
Online Access:	https://www.futuremedicine.com/doi/10.2217/mmt-2017-0025